A Phase I Study of the Interaction of Alcohol With Oral AFA-281 in Healthy Volunteers

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

September 1, 2029

Conditions

AlcoholAlcohol Use Disorders

Interventions

DRUG

AFA-281 is a small molecule, orally available

This is a study to evaluate the interaction of AFA-281 with alcohol

OTHER

Alcohol (Ethanol)

Alcohol will be administered in combination with AFA-281 or AFA-281 placebo

All Listed Sponsors

lead

Afasci Inc

INDUSTRY